FMR1 and fragile X syndrome: Although the μNET is only representative of early neurodevelopment and may not be able recapitulate all FMRP targets in the context of neural network maturation, which is more relatable to clinical symptoms of FXS, it is likely that the effect of FMR1 silencing in FXS can be manifested in different cellular processes during the course of development.